You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Univariate analysis for OS rate

From: Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer

  1-year OS rate (%) 2-year OS rate (%) P Value
Concurrence of metastasis in other sites
 Yes 59.4 59.4 0.740
 No 57.1 50.0  
Systemic therapy after SBRT
 Yes 71.4 71.4 0.119
 No 41.0 30.8  
Local control
 Yes 50.4 45.3 0.320
 No 100 100  
Metastasis in other sites after SBRT
 Yes 56.7 52.0 0.164
 No 66.7 66.7  
Age (years)
 <60 56.2 46.9 0.674
 ≥ 60 58.7 58.7